NFKB1 and sarcopenia: Metformin activates AMPK [114] and modulates diverse biological processes for muscle, such as glucose uptake, fatty acid oxidation, protein metabolism, autophagy, and mitochondrial function [115]; it also decreases the development of sarcopenia by reducing the inflammatory response by NF-κB [116].